Filipinos are increasingly turning to unregistered “lung support” supplements to manage serious respiratory conditions. Herbal capsules, specialty milk powders, and antioxidant blends are being promoted on social media as treatments for asthma, COPD, pneumonia, and even lung cancer. The Philippine College of Chest Physicians (PCCP) has issued a formal statement warning the public against these products. The Food and Drug Administration (FDA) has done the same, flagging specific products including “Lung Gold Milk” under Advisory No. 2024-1230.

The warning is clear. The products are unregistered. Their safety cannot be guaranteed. And there is no scientific evidence they treat any clinical lung condition.

Respiratory Disease Is a Serious and Growing Burden in the Philippines

The demand for quick-fix lung supplements does not exist in a vacuum. The Philippines carries a heavy respiratory disease burden, and many Filipinos are actively looking for affordable solutions.

An estimated 15% of Filipino adults had asthma as of 2014, a figure the Lancet Respiratory Medicine described as among the highest in the region. That disease alone accounts for nearly 700,000 disability-adjusted life years lost annually. Nearly half of all Filipinos with asthma have inadequately controlled disease.

COPD compounds the picture. A nationwide multicenter study using spirometry-confirmed data from 40 Philippine hospitals found that 76.5% of the 1,982 enrolled COPD patients had moderate to severe airflow obstruction. A separate study found a 35% COPD prevalence among Filipino smokers, with nearly 60% of those cases undiagnosed prior to the study. Biomass fuel use, a history of tuberculosis, and urban air pollution are major Philippine-specific risk factors.

Respiratory conditions are difficult and expensive to manage. Spirometry, the diagnostic gold standard for COPD and asthma, costs between PHP 2,000 and PHP 8,000 out of pocket. Hospitalization for an acute asthma attack averages over PHP 20,000, more than double what PhilHealth reimburses. Against this backdrop, an affordable supplement that claims to reverse COPD or clear the lungs sounds like a lifeline.

It is not.

These Products Are Not FDA-Registered and Their Safety Is Unverified

The PCCP statement is unambiguous on the regulatory status of these supplements: they are not FDA-approved or registered. The FDA has released multiple advisories against products making therapeutic lung claims, citing the agency’s inability to guarantee their safety, quality, or purity.

FDA Advisory No. 2024-1230 specifically flagged “Lung Gold Milk Raw Milk Powder Food Supplement,” which was being marketed with claims that it resolves pneumonia, bronchitis, asthma, and COPD in as little as seven days. Independent fact-checking by Vera Files confirmed that no such product held valid FDA registration at the time these claims were circulating.

These products reach patients before any clinical trial has been conducted. Their effects on vulnerable populations, including the elderly, children, and those with compromised lung function, have never been studied.

What Is Actually in These Products

The PCCP categorized the ingredients common to most lung supplements into three groups. Understanding what these ingredients are, and what they cannot do, is essential.

• Herbal ingredients typically include Mullein Leaf, long used in traditional medicine for coughs, though clinical evidence in humans remains limited. Quercetin, a plant-derived antioxidant, is under study for anti-inflammatory properties but is not a substitute for inhalers. N-Acetyl Cysteine (NAC), an amino acid with mucolytic properties, is used in clinical settings, but supplement formulations typically contain doses too low to produce a therapeutic effect.
• Vitamins and minerals such as Vitamin C, Vitamin D, and Magnesium provide general immune and muscle support. They cannot re-expand a collapsed lung, kill cancer cells, or open obstructed airways during an acute asthma attack. Framing them as respiratory treatments misrepresents their function entirely.
• Potential contaminants present the most serious risk. Because these products are manufactured in facilities with limited regulatory oversight, they may contain heavy metals including lead and arsenic. They may also contain unlisted stimulants that can dangerously increase heart rate, which is particularly hazardous for patients already hypoxic from compromised lung function.

The False Sense of Security Is the Real Danger

The PCCP specifically highlighted one consequence that extends beyond the products themselves: these supplements create a false sense of security. Patients who believe a supplement is managing their condition are less likely to seek proper medical care, more likely to delay or abandon prescribed treatments, and more likely to be in a worse clinical state when they eventually do present to a physician.

Shortness of breath, persistent cough, and chest pain are not symptoms to manage with a supplement. They are signals that require clinical evaluation. Delays in receiving evidence-based treatment for asthma, COPD, pneumonia, or lung cancer can be fatal.

Why These Products Spread Easily in the Philippine Context

Several structural factors make Filipinos particularly vulnerable to lung supplement marketing. Access to pulmonary specialists is concentrated in urban centers, particularly Metro Manila. Diagnostic equipment is scarce in community health facilities. The out-of-pocket cost of respiratory care is high relative to household income. Social media has made direct-to-consumer health product promotion inexpensive and difficult to regulate.

Sellers of these products understand the market they are targeting. The language they use mirrors legitimate medical terminology. Product names include clinical-sounding terms. Testimonials circulate on Facebook and TikTok, where they reach people who may have never had access to a pulmonologist.

The APMARGIN Perspective

The emergence and proliferation of unregistered lung supplements in the Philippines is not simply a product safety issue. It is a reflection of a healthcare access gap that leaves millions of Filipinos managing serious respiratory conditions without adequate medical support.

That gap is real. The demand it creates is understandable. But unregistered supplements marketed with false therapeutic claims exploit vulnerability rather than address it. They divert patients from evidence-based care, expose them to unverified substances, and delay diagnosis and treatment of conditions where time matters.

The PCCP’s statement and the FDA’s repeated advisories represent the medical and regulatory community doing its part. Expanding that message, translating it into community language, and pairing it with parallel efforts to improve respiratory care access must be the next step.

Filipinos with lung conditions deserve treatments that have been proven to work, not products that have simply been marketed well.

If you or someone you know is experiencing shortness of breath, persistent cough, chest pain, or difficulty breathing, consult a licensed healthcare professional immediately.

References

• Philippine College of Chest Physicians (PCCP). Statement on Respiratory Supplements and Vitamins. Issued 2025.
• Food and Drug Administration Philippines. FDA Advisory No. 2024-1230: Public Health Warning Against the Purchase and Consumption of Unregistered Food Supplement “Lung Gold Milk.” September 25, 2024.
• Vera Files. VERA FILES FACT CHECK: FB Pages Sell Fake Milk Product for Lung Detox. September 8, 2023.
• Esteban D, et al. Asthma care for all: lessons from the Philippines. Lancet Respiratory Medicine. May 2023.
• Philippine Academy of Family Physicians. Clinical Guidelines and Pathways for Bronchial Asthma. Filipino Family Physician Journal. Vol. 62, No. 1. June 2024.
• Abadilla A, et al. Characteristics and Treatment Patterns of COPD Patients According to GOLD Classification in the Philippines (CPASS Study). European Respiratory Society Congress. 2023.
• Pison C, et al. Burden of Obstructive Lung Disease in a Rural Setting in the Philippines. International Journal of Chronic Obstructive Pulmonary Disease. 2011.
• Researchgate. Prevalence and Risk Factors of COPD Among Smokers in the Philippines. August 2024.